ARTICLE | Company News
Cellartis, Novo Nordisk deal
October 27, 2008 7:00 AM UTC
The partners will develop insulin-producing cells from human stem cells to treat diabetes. Novo Nordisk will receive a non-exclusive license to Cellartis' human embryonic stem cell (hES) technology. T...